Mark L. Perry brings more than 30 years of experience serving in professional and management positions in the biotechnology industry. He is currently an independent consultant and board member of various companies, following a year as an Entrepreneur-in-Residence at Third Rock Ventures. From 2007 to 2011, Mr. Perry held the position of president and chief executive officer of Aerovance, a biotechnology company spun out of Bayer Corporation. Prior to joining Aerovance, he was the senior business advisor for Gilead Sciences, and was an executive officer of Gilead from 1994 to 2004, serving in a variety of capacities, including general counsel, chief financial officer and executive vice president of operations. He also spent 13 years with Cooley LLP, serving as a partner from 1987 to 1994.
Mr. Perry received his B.A. from the University of California, Berkeley and his J.D. from the University of California, Davis.